AU2001296854A1 - Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity - Google Patents
Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activityInfo
- Publication number
- AU2001296854A1 AU2001296854A1 AU2001296854A AU9685401A AU2001296854A1 AU 2001296854 A1 AU2001296854 A1 AU 2001296854A1 AU 2001296854 A AU2001296854 A AU 2001296854A AU 9685401 A AU9685401 A AU 9685401A AU 2001296854 A1 AU2001296854 A1 AU 2001296854A1
- Authority
- AU
- Australia
- Prior art keywords
- hadh2
- erab
- modulating
- inhibiting
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22612300P | 2000-08-18 | 2000-08-18 | |
US60226123 | 2000-08-18 | ||
PCT/US2001/041795 WO2002016365A1 (en) | 2000-08-18 | 2001-08-17 | Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001296854A1 true AU2001296854A1 (en) | 2002-03-04 |
Family
ID=22847647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001296854A Abandoned AU2001296854A1 (en) | 2000-08-18 | 2001-08-17 | Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
Country Status (14)
Country | Link |
---|---|
US (2) | US6964957B2 (pt) |
EP (2) | EP1311511A1 (pt) |
JP (2) | JP2004506737A (pt) |
AR (1) | AR035486A1 (pt) |
AU (1) | AU2001296854A1 (pt) |
BR (1) | BR0113461A (pt) |
CA (2) | CA2415182A1 (pt) |
GT (1) | GT200100169A (pt) |
HK (1) | HK1046288A1 (pt) |
MX (1) | MXPA03001455A (pt) |
PA (1) | PA8525801A1 (pt) |
PE (1) | PE20020394A1 (pt) |
UY (1) | UY26895A1 (pt) |
WO (1) | WO2002016365A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10221052A1 (de) * | 2002-05-10 | 2003-12-04 | Transmit Technologietransfer | Wirkstoffe zu Therapie, Diagnostik und Prophylaxe von Erkrankungen, bei denen abnorme Proteinstrukturen auftreten |
EP1627323A4 (en) * | 2003-05-06 | 2008-04-09 | New Century Pharmaceuticals | ALBUMIN FIXATION SITES FOR EVALUATING DRUG INTERACTIONS OR THE DEVELOPMENT OF MEDICAMENTS BASED ON THEIR ALBUMIN BINDING PROPERTIES |
EP1684705A4 (en) * | 2003-11-03 | 2008-02-20 | New Century Pharmaceuticals | ALBUMIN BINDING FACILITIES FOR THE EVALUATION OF MEDICAMENTAL INTERACTION EFFECTS AND METHOD FOR ASSESSING OR DESIGNING MEDICAMENT BASED ON THEIR ALBUMIN BONDING PROPERTIES |
WO2005117538A2 (en) * | 2004-04-12 | 2005-12-15 | The Trustees Of Columbia University In The City Of New York | METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION |
PL2813225T3 (pl) * | 2004-09-24 | 2018-11-30 | University Of Maryland, Baltimore | Sposób leczenia zatrucia związkami fosforoorganicznymi |
US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
WO2010118367A2 (en) * | 2009-04-10 | 2010-10-14 | Progenics Pharmaceuticals, Inc. | Antiviral pyrimidines |
TWI770525B (zh) * | 2014-12-30 | 2022-07-11 | 美商瓦洛健康公司 | 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶 |
MA41291A (fr) | 2014-12-30 | 2017-11-07 | Forma Therapeutics Inc | Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer |
WO2016126929A1 (en) | 2015-02-05 | 2016-08-11 | Forma Therapeutics, Inc. | Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors |
WO2016126926A1 (en) | 2015-02-05 | 2016-08-11 | Forma Therapeutics, Inc. | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors |
JP2018504432A (ja) | 2015-02-05 | 2018-02-15 | フォーマ セラピューティクス,インコーポレイテッド | ユビキチン特異的プロテアーゼ7阻害物質としてのイソチアゾロピリミジノン、ピラゾロピリミジノン及びピロロピリミジノン |
WO2023146880A1 (en) * | 2022-01-25 | 2023-08-03 | Board Of Regents Of The University Of Nebraska | Functionalized allopurinol derivatives for treatment of alzheimer's disease |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3165520A (en) | 1965-01-12 | Certificate of correction | ||
US4666908A (en) | 1985-04-05 | 1987-05-19 | Warner-Lambert Company | 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use |
EP0347146B1 (en) | 1988-06-16 | 1993-09-01 | Smith Kline & French Laboratories Limited | Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
US5109119A (en) * | 1989-06-06 | 1992-04-28 | Schering Corporation | Crystalline r-h-gm-csf and method |
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9114760D0 (en) | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
US5294612A (en) * | 1992-03-30 | 1994-03-15 | Sterling Winthrop Inc. | 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof |
US5322933A (en) * | 1992-05-07 | 1994-06-21 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Crystal structure of TGF-β-2 |
PH31122A (en) | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
US5294611A (en) | 1993-04-23 | 1994-03-15 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
US5556778A (en) * | 1994-04-28 | 1996-09-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Crystalline Inha Enzyme-NADH Complex |
PL181895B1 (pl) * | 1994-06-16 | 2001-10-31 | Pfizer | Nowe pirazolo-i pirolopirydyny _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ PL PL PL PL |
US5756466A (en) | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
GB9423910D0 (en) | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
US5656629A (en) | 1995-03-10 | 1997-08-12 | Sanofi Winthrop, Inc. | 6-substituted pyrazolo (3,4-d)pyrimidin-4-ones and compositions and methods of use thereof |
US6153652A (en) | 1996-11-22 | 2000-11-28 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6555651B2 (en) | 1997-10-09 | 2003-04-29 | The Trustees Of Columbia University In The City Of New York | Ligand binding site of rage and uses thereof |
US6268479B1 (en) * | 1997-03-12 | 2001-07-31 | The Trustees Of Columbia University In The City Of New York | Intracellular amyloid-beta peptide binding (ERAB) polypeptide |
EP1019501A1 (en) | 1997-03-14 | 2000-07-19 | Otsuka Pharmaceutical Co., Ltd. | Novel pyrimidine derivative |
KR100390612B1 (ko) | 1997-04-25 | 2003-07-07 | 화이자 인코포레이티드 | 타입 5 시클릭 구아노신 3',5'-모노포스페이트포스포디에스테라제를 억제하는 성기능 장애 치료용피라졸로피리미디논 제조용 중간체의 제조 방법 |
US5872011A (en) * | 1997-06-13 | 1999-02-16 | The Rockefeller University | Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof |
US6020162A (en) * | 1997-06-13 | 2000-02-01 | The Rockefeller University | Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof |
ATE355841T1 (de) * | 1997-12-13 | 2007-03-15 | Bristol Myers Squibb Co | Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer |
US6194410B1 (en) | 1998-03-11 | 2001-02-27 | Hoffman-La Roche Inc. | Pyrazolopyrimidine and pyrazolines and process for preparation thereof |
GB9822238D0 (en) | 1998-10-12 | 1998-12-09 | Pfizer Ltd | Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof |
AUPP672198A0 (en) * | 1998-10-23 | 1998-11-19 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
MXPA01009863A (es) | 1999-06-10 | 2002-05-06 | Warner Lambert Co | Derivados de rodanina y su uso en la inhibicion y formacion de imagenes amiloides. |
OA11958A (en) | 1999-06-10 | 2006-04-13 | Warner Lambert Co | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives. |
EP1192143A1 (en) | 1999-06-10 | 2002-04-03 | Warner-Lambert Company | Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
AU6766800A (en) | 1999-08-13 | 2001-03-13 | Trustees Of Columbia University In The City Of New York, The | Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
-
2001
- 2001-08-16 PE PE2001000819A patent/PE20020394A1/es not_active Application Discontinuation
- 2001-08-17 AR ARP010103959A patent/AR035486A1/es not_active Application Discontinuation
- 2001-08-17 BR BR0113461-2A patent/BR0113461A/pt not_active IP Right Cessation
- 2001-08-17 JP JP2002521466A patent/JP2004506737A/ja not_active Withdrawn
- 2001-08-17 CA CA002415182A patent/CA2415182A1/en not_active Abandoned
- 2001-08-17 WO PCT/US2001/041795 patent/WO2002016365A1/en not_active Application Discontinuation
- 2001-08-17 US US09/931,166 patent/US6964957B2/en not_active Expired - Fee Related
- 2001-08-17 GT GT200100169A patent/GT200100169A/es unknown
- 2001-08-17 PA PA20018525801A patent/PA8525801A1/es unknown
- 2001-08-17 US US09/931,186 patent/US20020132319A1/en not_active Abandoned
- 2001-08-17 EP EP01977762A patent/EP1311511A1/en not_active Withdrawn
- 2001-08-17 AU AU2001296854A patent/AU2001296854A1/en not_active Abandoned
- 2001-08-17 UY UY26895A patent/UY26895A1/es not_active Application Discontinuation
- 2001-08-17 MX MXPA03001455A patent/MXPA03001455A/es unknown
- 2001-08-17 CA CA002354653A patent/CA2354653A1/en not_active Abandoned
- 2001-08-20 JP JP2001249448A patent/JP2002360269A/ja active Pending
- 2001-08-20 EP EP01307075A patent/EP1223176A3/en not_active Withdrawn
-
2002
- 2002-10-15 HK HK02107461.3A patent/HK1046288A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1046288A1 (zh) | 2003-01-03 |
JP2002360269A (ja) | 2002-12-17 |
CA2354653A1 (en) | 2002-02-18 |
BR0113461A (pt) | 2003-07-01 |
GT200100169A (es) | 2002-05-16 |
EP1223176A2 (en) | 2002-07-17 |
AR035486A1 (es) | 2004-06-02 |
US20020132319A1 (en) | 2002-09-19 |
EP1311511A1 (en) | 2003-05-21 |
CA2415182A1 (en) | 2002-02-28 |
US20020065292A1 (en) | 2002-05-30 |
PE20020394A1 (es) | 2002-06-21 |
UY26895A1 (es) | 2002-04-26 |
US6964957B2 (en) | 2005-11-15 |
MXPA03001455A (es) | 2004-05-04 |
JP2004506737A (ja) | 2004-03-04 |
PA8525801A1 (es) | 2002-08-29 |
EP1223176A3 (en) | 2002-10-23 |
WO2002016365A1 (en) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU781269C (en) | Pharmaceutical compositions | |
ZA200203040B (en) | Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation. | |
ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
HUP0200355A2 (en) | 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use | |
HUP0202490A3 (en) | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU2002328494A1 (en) | Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients | |
AU2002364342A1 (en) | Heteroxylan film-forming composition for making capsules and resulting capsules | |
AU2001284149A1 (en) | Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same | |
AU2001281171A1 (en) | Medication dispensing system | |
AU2001296854A1 (en) | Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity | |
AU2001292864A1 (en) | Methods and compositions for modulating angiogenesis | |
EP1138643A3 (en) | Binder for hydraulic compositions, and hydraulic compositions containing the same | |
ZA200110150B (en) | Streptogramin derivatives, preparation and compositions containing them. | |
AU2001292331A1 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
AU2001292331A2 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU7937500A (en) | Pharmaceutical composition containing midazolam | |
AU2002360117A1 (en) | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | |
AU2001284167A1 (en) | Sprinkler system | |
AU2362701A (en) | Fragrance or flavor formulation | |
HK1052168A1 (en) | N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them. | |
AU4085201A (en) | Pharmaceutical composition |